Amplification of KCNMA 1 : A Potential Therapeutic Target in Prostate Cancer

Abstract

Prostate cancer is the most common cancer in males and the second leading cause of cancer deaths in western countries. Although most prostate cancers initially respond well to androgen withdrawal, they become inevitably resistant to this treatment and progress to hormone-insensitive disease after only a few months or years. The therapeutic options in these… (More)

11 Figures and Tables

Topics

  • Presentations referencing similar topics